<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03249246</url>
  </required_header>
  <id_info>
    <org_study_id>TurkishICS</org_study_id>
    <nct_id>NCT03249246</nct_id>
  </id_info>
  <brief_title>Epidemiology of Sepsis in Turkish ICUs.</brief_title>
  <official_title>Epidemiology of Sepsis in Turkish ICUs :a National Point Prevalence Multi-centre Study.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nur Baykara</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Turkish Society of Intensive Care, Sepsis Study Group</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Turkish Intensive Care Society</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The prevalence and mortality of sepsis in Turkey is not know at large. Turkish Society of
      Intensive Care Medicine, Sepsis Study Group conducted a multi-centre,point prevalence survey
      to determine the prevalence, causative micro-organisms and outcome of sepsis in Turkish ICUs.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 27, 2016</start_date>
  <completion_date type="Actual">February 27, 2016</completion_date>
  <primary_completion_date type="Actual">January 28, 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Prevalence of sepsis</measure>
    <time_frame>Up to 12 weeks.</time_frame>
    <description>The prevalence of sepsis,Severe sepsis and septic shock on study day</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mortality rate of sepsis</measure>
    <time_frame>Mortality at 30 days</time_frame>
    <description>Mortality rate of septic shock</description>
  </secondary_outcome>
  <number_of_groups>4</number_of_groups>
  <enrollment type="Actual">1499</enrollment>
  <condition>Sepsis</condition>
  <condition>Septic Shock</condition>
  <condition>Severe Sepsis</condition>
  <arm_group>
    <arm_group_label>Infection only</arm_group_label>
    <description>The patients have only infection</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Infection + SIRS</arm_group_label>
    <description>Patients have infection plus systemic inflammatory response syndrome (SIRS)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Severe sepsis</arm_group_label>
    <description>Septic patients with newly developed organ dysfunctions</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Septic shock</arm_group_label>
    <description>Sepsis plus sepsis related hypotension</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>No intervention</intervention_name>
    <arm_group_label>Infection only</arm_group_label>
    <arm_group_label>Infection + SIRS</arm_group_label>
    <arm_group_label>Severe sepsis</arm_group_label>
    <arm_group_label>Septic shock</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All patients (&gt;18 yr)present on the participating ICU or admitted to participating ICUs on
        study day
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:All patients present on or admitted to participating ICU on study day.

        Exclusion Criteria:

          -  Age&lt;18 years

          -  Patients who underwent cardiovascular surgery.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <reference>
    <citation>Rhodes A, Phillips G, Beale R, Cecconi M, Chiche JD, De Backer D, Divatia J, Du B, Evans L, Ferrer R, Girardis M, Koulenti D, Machado F, Simpson SQ, Tan CC, Wittebole X, Levy M. The Surviving Sepsis Campaign bundles and outcome: results from the International Multicentre Prevalence Study on Sepsis (the IMPreSS study). Intensive Care Med. 2015 Sep;41(9):1620-8. doi: 10.1007/s00134-015-3906-y. Epub 2015 Jun 25.</citation>
    <PMID>26109396</PMID>
  </reference>
  <reference>
    <citation>Falagas ME, Rafailidis PI, Kofteridis D, Virtzili S, Chelvatzoglou FC, Papaioannou V, Maraki S, Samonis G, Michalopoulos A. Risk factors of carbapenem-resistant Klebsiella pneumoniae infections: a matched case control study. J Antimicrob Chemother. 2007 Nov;60(5):1124-30. Epub 2007 Sep 20.</citation>
    <PMID>17884829</PMID>
  </reference>
  <results_reference>
    <citation>Fleischmann C, Scherag A, Adhikari NK, Hartog CS, Tsaganos T, Schlattmann P, Angus DC, Reinhart K; International Forum of Acute Care Trialists. Assessment of Global Incidence and Mortality of Hospital-treated Sepsis. Current Estimates and Limitations. Am J Respir Crit Care Med. 2016 Feb 1;193(3):259-72. doi: 10.1164/rccm.201504-0781OC.</citation>
    <PMID>26414292</PMID>
  </results_reference>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 9, 2017</study_first_submitted>
  <study_first_submitted_qc>August 11, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">August 15, 2017</study_first_posted>
  <last_update_submitted>August 11, 2017</last_update_submitted>
  <last_update_submitted_qc>August 11, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 15, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Turkish Intensive Care Society</investigator_affiliation>
    <investigator_full_name>Nur Baykara</investigator_full_name>
    <investigator_title>Prof.Dr.Nur Baykara</investigator_title>
  </responsible_party>
  <keyword>Sepsis</keyword>
  <keyword>ICU</keyword>
  <keyword>Point prevalence</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sepsis</mesh_term>
    <mesh_term>Toxemia</mesh_term>
    <mesh_term>Shock, Septic</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

